TOMI Environmental Solutions Announces Initiation of Equity Analyst Coverage by H.C. Wainwright with a “Buy” Recommendation
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced that H.C. Wainwright has initiated analyst coverage of its common stock. This move aims to increase market visibility and enhance the understanding of TOMI's disinfection solutions utilizing its Binary Ionization Technology (BIT). The company emphasizes that analysts' reports reflect their perspectives and not necessarily those of TOMI. The 31-page report is accessible through H.C. Wainwright. TOMI's BIT platform is used widely across various sectors, including healthcare and food processing, underscoring its importance in infection prevention.
- H.C. Wainwright has initiated analyst coverage on TOMI Environmental Solutions, which may boost market interest and visibility.
- TOMI's technology is widely applicable across multiple sectors including healthcare, enhancing its revenue potential.
- TOMI's forward-looking statements include risks related to reliance on few products for revenue, which could impact financial stability.
- Potential risks from the ongoing COVID-19 pandemic may adversely affect business operations and customer engagement.
FREDERICK, Md., Dec. 23, 2021 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced that H.C. Wainwright has initiated analyst coverage of the Company’s common stock.
All reports on TOMI prepared by analysts represent the views of those analysts and are not necessarily those of TOMI. TOMI is not responsible for the content, accuracy, or timelines provided by analysts.
A copy of the 31-page analyst report can be obtained directly from the bank.
By referring to these analysts or distributing their opinions, TOMI does not in any way commit itself to the validity of such information, conclusions or recommendations.
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.
TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.
TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.
For additional information, please visit http://www.tomimist.com/ or contact us at info@tomimist.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contain forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to analyst coverage of our common stock. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, the impact of COVID-19 pandemic on our business and customers; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
INVESTOR RELATIONS CONTACT
John Nesbett/Jennifer Belodeau
IMS Investor Relations
jnesbett@imsinvestorrelations.com
FAQ
What analyst firm initiated coverage on TOMZ?
When did H.C. Wainwright initiate coverage on TOMZ?
What technology does TOMI utilize for disinfection?
What sectors does TOMI's technology serve?
Where can I find the analyst report on TOMZ?
